유방암 환자의 인지기능 측정도구 개발 = Development of the Cognitive Function Scale for Breast Cancer Patients

다국어 초록 (Multilingual Abstract)

Purpose: This is the methodological study to develop the cognitive function scale for breast cancer patients. Methods: Study was consisted with 1st and 2nd items developing and testify for reliability and validity of them. 94 breast cancer patients in 2 university hospitals and 1 general hospitals responded to a questionnaire that assessed cognitive function scale. Collected data were analysed using the program SPSS/PC Win 21.0. Structural validity was determined factor analysis and convergent validity. This method yielded Cronbach’s α value as an internal consistency for the reliability. Results: Factor analysis resulted in six factors and 24 items accounted for 76.31% of the variance. Cronbach’s α of scale developed was high as a .95. Conclusion: The developed cognitive function scale in breast cancer patients scale has reliability and validity as linear analogue scale witch quantitatively measure the subjectivity. Over these results, providing the way on an assessment in cognitive function in effect for breast cancer patients, it is supposed to contribute the development of nursing knowledge about the cognitive function in breast cancer patients.

목차 (Table of Contents)

• 서론
• 연구방법
• 연구결과
• 논의
• 결론
• REFERENCES

참고문헌 (Reference)

1 이정란, "항암화학요법을 받는 유방암 환자의 인지기능감퇴와 삶의 질에 관한 연구: 건강증진행위의 매개효과" 한국성인간호학회 28 (28): 202-212, 2016

2 김경덕, "유방암 생존자와 중년여성의 갱년기 증상 및 인지기능 비교" 대한종양간호학회 13 (13): 11-17, 2013

3 오복자, "대장암환자의 항암화학요법 관련 인지손상과 삶의 질: 심리적 디스트레스(우울·불안)의 매개효과" 한국간호과학회 46 (46): 19-28, 2016

4 Wefel JS, "The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial" 100 : 2292-2299, 2004

5 Tager FA, "The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study" 123 : 25-34, 2010

6 Collins B, "Study of the cognitive effects of chemotherapy: considerations in selection of a control group" 35 : 435-444, 2013

7 Shilling V, "Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer" 11 : 6-15, 2007

8 Cimprich B, "Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer" 14 : 70-78, 2005

9 Lee EO, "Nursing research and statistical analysis" Soomoonsa 2009

10 Yamada TH, "Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy" 22 : 48-54, 2010

11 Calvio L, "Measures of cognitive function and work in occupationally active breast cancer survivors" 52 : 219-227, 2010

12 Lejbak L, "Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer" 32 : 836-846, 2010

13 Chung BY, "Development and application of cognitive function enhancement program for breast cancer patients receiving chemotherapy" Ministry of Education, Science and Technology 2013

14 Quesnel C, "Cognitive impairments associated with breast cancer treatments: results from a longitudinal study" 116 : 113-123, 2009

15 Brezden CB, "Cognitive function in breast cancer patients receiving adjuvant chemotherapy" 18 : 2695-2701, 2000

16 Debess J, "Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study" 121 : 91-100, 2010

17 Shulman KI, "Clock-drawing: is it the ideal cognitive screening test?" 15 : 548-561, 2000

18 Bender CM, "Chemotherapy may have small to moderate negative effects on cognitive functioning" 32 : 316-319, 2006

19 Statistics Korea, "Cancer registration statistics: 24 cancers"

20 Shockney LD, "Breast cancer survivorship care: a resource for nurses" Jones and Bartlett 2011

21 Vardy J, "Assessing cognitive function in cancer patients" 14 : 1111-1118, 2006

22 Freeman JR, "Assessing cognitive dysfunction in breast cancer: what are the tools?" 3 (3): S91-S99, 2002

23 Harvan JR, "An evaluation of dementia screening in the primary care setting" 18 : 351-360, 2006

24 Wefel JS, "Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer" 116 : 3348-3356, 2010

25 Jansen CE, "A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients" 19 : 1647-1656, 2011

26 Jansen CE, "A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer" 34 : 997-1005, 2007